Promising applications such as non-invasive medical diagnostics and molecular level chemical interaction analysis will drive technology development, finds Frost & Sullivan’s TechVision team
London, 22 November 2016 – The advent of Internet of Things (IoT) as well as user demand for enhanced safety, non-invasive and independent assistive technologies are driving nanosensor technology. A research and development (R&D) boom is expected as sensor manufacturers explore a wide range of applications across healthcare, chemicals, automotive, and military and defense verticals. Cost, low user awareness, regulatory hurdles, and technology complexity, which hinder widespread adoption in the short term, will be rapidly overcome as nanosensing enables next-generation devices with higher sensitivity, selectivity and multiparameter sensing capabilities.
“Various global government agencies are actively funding the R&D of nanosensor technology in applications such as non-invasive medical diagnostics, detection of chemical hazards and analysis of molecular level chemical interactions,” said TechVision Research Analyst Varun Babu. “The rising number of patents filed over the past few years clearly indicates the potential of the technology and makes a case for collaborations and acquisitions to ensure rapid faster commercialization.”
Advancements in Nanosensors, recent analysis from Frost & Sullivan’s TechVision (Sensors and Instrumentation) subscription, details recent advancements in nanosensors and the impact on current and future applications across various industrial sectors. Among others, the analysis covers such aspects as: technology roadmap, intellectual property analysis, funding scenario, key innovations, application landscape, potential points of convergence, companies to watch, and growth strategies.
Click here for complimentary access to more information on this analysis and to register for a Growth Strategy Dialogue, a free interactive workshop with Frost & Sullivan’s thought leaders.
Innovative nanosensor companies already leading the way in various verticals include:
- Healthcare: T2 Biosystems Inc., BreathDx Inc. Vista Therapeutics Inc.;
- Industrial and Chemical: Applied Nanotech Inc., INanoBio Inc., Tracense Systems Ltd.;
- Food Safety and Environmental Safety: N5 Sensors Inc., nanoTox Inc.
“The APAC region leads in the development of nanosensor technology; China has files several patents, while Korea and Japan have emerged as promising markets” noted Varun Babu. “North America is the next most lucrative market due to strong support from the federal government in terms of grants to academic institutions and companies to develop highly sensitive nanosensing devices.”
Frost & Sullivan’s global TechVision practice is focused on innovation, disruption and convergence, and provides a variety of technology-based alerts, newsletters and research services as well as growth consulting services. Its premier offering, the TechVision programme, identifies and evaluates the most valuable emerging and disruptive technologies enabling products with near-term potential. A unique feature of the TechVision programme is an annual selection of 50 technologies that can generate convergence scenarios, possibly disrupt the innovation landscape, and drive transformational growth. View a summary of our TechVision program by clicking on the following link: http://ifrost.frost.com/TechVision_Demo.